New Developments In Coronary Artery Stenting Including The Status Of Bioresorbable Drug Eluting Stents

Can Decreasing LDL-C Sharply Produce Plaque Regression In The Coronary Arteries; In Carotid Arteries: What Drugs Should Be Used And What Should The LDL-C Goal Be

DEBATE: Lowering LDL-C Levels With Statins And PCSK-9 Inhibitors In Vascular And At Risk Patients Prevents Cardiovascular Events And Deaths, Is Reasonably Safe And Helps Patients To Have Longer And Better Lives

The Less Than Stellar 3-Year Results Of The Absorb Drug Eluting Bioresorbable Stent (BRSs) (Abbott) In Coronary Lesions May Be Due To Variable And Imperfect Implantation Techniques And Sizing: Small Arteries May Be A Problem: What Is The Future For BRSs